Fig. 7From: Anticancer and antimicrobial potential of enterocin 12a from Enterococcus faeciumMorphological changes induced in HCT-15 after 24 h treatment with enterocin 12a (1 μg/ml). (A) Giemsa-stained untreated control cells (B) Giemsa-stained enterocin-treated cells (C) PI and Hoechst 33342 co-stained untreated control cells (D) PI and Hoechst 33342 co-stained enterocin-treated cells. Yellow arrows show cell shrinkage, and red arrows show nuclear fragmentationBack to article page